We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXST icon
4251
RxSight
RXST
$292M
$9K ﹤0.01%
731
-444
-38% -$5.4K
RZLT icon
4252
Rezolute
RZLT
$444M
$9K ﹤0.01%
4,599
+2,323
+102% +$4.35K
SACH
4253
Sachem Capital Corp
SACH
$38.1M
$9K ﹤0.01%
2,720
+100
+4% +$361
SAMG icon
4254
Silvercrest Asset Management
SAMG
$77.7M
$9K ﹤0.01%
485
-226
-32% -$4.07K
SB icon
4255
Safe Bulkers
SB
$790M
$9K ﹤0.01%
3,170
-1,126
-26% -$3.12K
SBEV icon
4256
Splash Beverage Group
SBEV
$2.53M
$9K ﹤0.01%
57
-41
-42% -$7.19K
SBFG icon
4257
SB Financial Group
SBFG
$170M
$9K ﹤0.01%
528
+201
+61% +$3.37K
SES icon
4258
SES AI
SES
$222M
$9K ﹤0.01%
2,970
+1,394
+88% +$6.74K
SGHT icon
4259
Sight Sciences
SGHT
$461M
$9K ﹤0.01%
749
-630
-46% -$5.99K
SLNG icon
4260
Stabilis Solutions
SLNG
$120M
$9K ﹤0.01%
1,580
+459
+41% +$3.31K
SLVM icon
4261
Sylvamo
SLVM
$1.53B
$9K ﹤0.01%
199
-1,635
-89% -$78.5K
SNCY
4262
DELISTED
Sun Country Airlines
SNCY
$9K ﹤0.01%
618
-13,189
-96% -$231K
SNGX icon
4263
Soligenix
SNGX
$8.57M
$9K ﹤0.01%
80
+3
+4% +$433
SNOA icon
4264
Sonoma Pharmaceuticals
SNOA
$6.27M
$9K ﹤0.01%
403
+157
+64% +$5.59K
SPH icon
4265
Suburban Propane Partners
SPH
$1.18B
$9K ﹤0.01%
580
-229
-28% -$3.67K
SSKN
4266
DELISTED
Strata Skin Sciences
SSKN
$9K ﹤0.01%
1,195
+414
+53% +$3.55K
SSTK icon
4267
Shutterstock
SSTK
$210M
$9K ﹤0.01%
166
-4,037
-96% -$206K
STRS
4268
DELISTED
STRATUS PPTYS INC
STRS
$9K ﹤0.01%
457
-173
-27% -$4.15K
SUPN icon
4269
Supernus Pharmaceuticals
SUPN
$2.77B
$9K ﹤0.01%
271
-3,561
-93% -$124K
SUSB icon
4270
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
$9K ﹤0.01%
+388
New +$9.16K
SWKH
4271
DELISTED
SWK Holdings
SWKH
$9K ﹤0.01%
630
-392
-38% -$5.77K
TAIT
4272
DELISTED
Taitron Components
TAIT
$9K ﹤0.01%
2,575
+1,394
+118% +$5.25K
TBI
4273
Trueblue
TBI
$317M
$9K ﹤0.01%
442
-2,963
-87% -$60.1K
TLPH icon
4274
Talphera
TLPH
$62.8M
$9K ﹤0.01%
3,867
+1,541
+66% +$4.34K
TRML
4275
DELISTED
Tourmaline Bio
TRML
$9K ﹤0.01%
903
+39
+5% +$627

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.